|
Volumn 347, Issue , 2013, Pages
|
Second study on valsartan is threatened with retraction over alleged data manipulation.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
DRUG DERIVATIVE;
TETRAZOLE DERIVATIVE;
VALINE;
VALSARTAN;
CLINICAL PRACTICE;
DRUG ERUPTION;
DRUG SURVEILLANCE PROGRAM;
FEMALE;
HUMAN;
MALE;
NOTE;
PUBLISHING;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANTIHYPERTENSIVE AGENTS;
DRUG ERUPTIONS;
FEMALE;
HUMANS;
MALE;
PHYSICIAN'S PRACTICE PATTERNS;
RETRACTION OF PUBLICATION AS TOPIC;
TETRAZOLES;
VALINE;
|
EID: 84884742260
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f4920 Document Type: Note |
Times cited : (1)
|
References (0)
|